HIV Drug-Hormone interaction study in transgender women ends early
NCT ID NCT06005610
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 33 times
Summary
This study looked at how feminizing hormone therapy (estrogen) interacts with HIV medications in transgender women living with HIV. Researchers wanted to see if the hormones affect drug levels in the blood. The study enrolled 93 adults and was stopped early, but the goal was to provide better treatment guidance for this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV I INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barranco CRS (11301)
Lima, 4, Peru
-
Case CRS (2501)
Cleveland, Ohio, 44106, United States
-
Chapel Hill CRS (3201)
Chapel Hill, North Carolina, 27599-7215, United States
-
Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS (31784)
Chiang Mai, 50200, Thailand
-
Greensboro CRS (3203)
Greensboro, North Carolina, 27401, United States
-
Houston AIDS Research Team CRS (31473)
Houston, Texas, 77030, United States
-
Johns Hopkins University CRS (201)
Baltimore, Maryland, 21205, United States
-
New Jersey Medical School Clinical Research Center CRS (31786)
Newark, New Jersey, 07103, United States
-
Nutrición-Mexico CRS (32078)
Mexico City, Tlalpan, 14080, Mexico
-
Thai Red Cross AIDS Research Centre (TRC-ARC) CRS (31802)
Bangkok, Patumwan, 10330, Thailand
-
The Ponce de Leon Center CRS (5802)
Atlanta, Georgia, 30308, United States
-
UCSD Antiviral Research Center CRS (701)
San Diego, California, 92103, United States
-
University of California, San Francisco HIV/AIDS CRS (801)
San Francisco, California, 94110, United States
-
University of Colorado Hospital CRS (6101)
Aurora, Colorado, 80045, United States
-
Vanderbilt Therapeutics CRS (3652)
Nashville, Tennessee, 37204, United States
-
Washington University Therapeutics (WT) CRS (2101)
St Louis, Missouri, 63110-1010, United States
-
Weill Cornell Uptown CRS (site 7803)
New York, New York, 10065, United States
-
Whitman-Walker Institute, Inc. CRS (31791)
Washington D.C., District of Columbia, 20005, United States
Conditions
Explore the condition pages connected to this study.